Infraredx, Inc., a Nipro company, is advancing the diagnosis and management of coronary artery
disease by providing cardiologists with the most precise imaging tools required to predict and
ultimately prevent heart attacks. Its Makoto™ Intravascular Imaging System, with
accompanying Dualpro™ IVUS+NIRS catheter, is the only technology on the market that is
FDA-cleared to identify patients and plaques at an increased risk of MACE. Infraredx, a Nipro Company is dedicated to advancing this important field of research and conducting landmark clinical trials to transform how we view and treat heart disease. The Nipro OKAY II Y-Connector is now available in the USA! Stop by booth #4054 for a demo of the Makoto Imaging System, the Dualpro IVUS+NIRS Catheter and the OKAY II Y-Connector.
Additional Info
ACC.20/WCC Learning Pathways? (select all that apply)
Interventional Cardiology